Update on the epidemiology of carbapenemases in Latin America and the Caribbean
Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public heal...
- Autores:
-
Garcia Betancur, Juan Carlos
Appel, Tobias Manuel
Esparza, Germán Francisco
Gales, Ana
Levy-Hara, Gabriel
Cornistein, Wanda
Vega, Silvio
Nuñez, Duilio
Cuellar, Luis
Bavestrello, Luis
Castañeda-Méndez, Paulo F.
Villalobos-Vindas, Juan M.
Villegas, María Virginia
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_6501
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/4222
- Acceso en línea:
- https://hdl.handle.net/20.500.12495/4222
https://doi.org/10.1080/14787210.2020.1813023
- Palabra clave:
- Acinetobacter baumannii
Carbapenem resistance
Carbapenem-resistant Enterobacterales (CRE)
Carbapenemases
Carbapenems
Klebsiella pneumoniae
Pseudomonas aeruginosa
- Rights
- License
- Acceso abierto
| Summary: | Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. Areas covered: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. Expert opinion: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy. |
|---|
